We are live on ! Find out more
LIAN

LianBio American Depositary Shares
LIAN

Delisted

LIAN was delisted on the 18th of March, 2024.

Back to rankings

40 hedge funds and large institutions have $133M invested in LianBio American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

9% less funds holding

Funds holding: 44 → 40 (-4)

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

21% less capital invested

Capital invested by funds: $168M → $133M (-$34.7M)

36% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 11

Holders
40
Holders Change
-4
Holders Change %
-9.09%
% of All Funds
0.64%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
7
Increased
8
Reduced
10
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$172K
2
AAA
Affinity Asset Advisors
New York
+$156K
3
CIC
Cornercap Investment Counsel
Georgia
+$131K
4
TCM
Tang Capital Management
California
+$92.9K
5
Jane Street
Jane Street
New York
+$74.1K

Top Sellers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$1.42M
2
Citadel Advisors
Citadel Advisors
Florida
-$1.09M
3
VA
VR Adviser
New York
-$912K
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$858K
5
Marshall Wace
Marshall Wace
United Kingdom
-$410K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$94.4M – – –
VA
2
VR Adviser
New York
$7.86M -$912K -585,294 -11%
Viking Global Investors
3
Viking Global Investors
Connecticut
$5.85M – – –
TCM
4
Tybourne Capital Management
Hong Kong
$5.42M – – –
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$4.4M -$220K -141,360 -5%
VVA
6
Vida Ventures Advisors
Massachusetts
$3.74M – – –
Wellington Management Group
7
Wellington Management Group
Massachusetts
$1.69M – – –
BlackRock
8
BlackRock
New York
$1.68M – – –
SG
9
SCHF (GPE)
Wyoming
$1.54M – – –
Citigroup
10
Citigroup
New York
$1.16M – – –
AAA
11
Affinity Asset Advisors
New York
$1.07M +$156K +100,000 +18%
Millennium Management
12
Millennium Management
New York
$526K +$172K +110,128 +52%
Renaissance Technologies
13
Renaissance Technologies
New York
$477K -$38K -24,378 -8%
LGM
14
Logos Global Management
California
$459K -$43.5K -27,908 -9%
CC
15
Casdin Capital
New York
$339K – – –
TD Asset Management
16
TD Asset Management
Ontario, Canada
$293K – – –
IAM
17
Innovis Asset Management
Illinois
$289K +$275K +176,192 New
CIC
18
Cornercap Investment Counsel
Georgia
$272K +$131K +83,888 +103%
Citadel Advisors
19
Citadel Advisors
Florida
$233K -$1.09M -697,976 -83%
2L
20
22NW LP
Washington
$232K – – –
MA
21
MYDA Advisors
New York
$221K +$23.4K +15,000 +13%
Barclays
22
Barclays
United Kingdom
$211K -$218K -139,672 -52%
Manulife (Manufacturers Life Insurance)
23
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$182K – – –
Thrivent Financial for Lutherans
24
Thrivent Financial for Lutherans
Minnesota
$133K +$326 +209 +0.3%
Victory Capital Management
25
Victory Capital Management
Texas
$106K -$170K -108,954 -63%
1
2

LIAN Hedge Fund Activity: Q4 2022 in Review

40 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in LianBio American Depositary Shares (LIAN) for Q4 2022, worth a combined $133M — down 21% from $168M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of LIAN and 7 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 8 added.

The largest buyer was Millennium Management, adding an estimated $172K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $1.42M sold.

  • 40 institutional investors held LianBio American Depositary Shares (LIAN) as of Q4 2022, down from 44 in Q3 2022.
  • Funds reported $133M of LianBio American Depositary Shares stock for Q4 2022, down 21% quarter-over-quarter.
  • 7 funds opened new LianBio American Depositary Shares positions in Q4 2022 and 11 closed out, a net change of -4 holders.
  • The largest LianBio American Depositary Shares buyer in Q4 2022 was Millennium Management, an estimated $172K added.
  • The largest LianBio American Depositary Shares seller in Q4 2022 was Hudson Bay Capital Management, an estimated $1.42M sold.

Based on aggregated 13F filings for Q4 2022.